A Randomised, Placebo-Controlled Phase 3 Study To Evaluate The Efficacy And Safety Of Asp0113, A First-In-Class, Dna-Based Vaccine In Cmv-Seropositive Allogeneic Haematopoietic Cell Transplant Recipients

BONE MARROW TRANSPLANTATION(2019)

引用 0|浏览3
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要